D+Q works by inhibiting pro-survival pathways (tyrosine kinases and Bcl-2 family) broadlythese pathways are also present in non-senescent cells, creating off-target effects
In people with Hashimotos, this mechanism can be especially helpful
The conservative recommendation used in practice is 28 days
Red dotted lines indicate hydrogen bonds
Costa MAD, Fernandes GZ, Maiochi E, Ebs MFP, Dars FDS, Bolan SJ, Costa RRN, de Rezende VL, da Silva GC, Bitencourt RM, Gonalves CL
Segundo Eli Lilly, o medicamento ainda est em estudos e no h data para o lanamento, embora especialistas indiquem que a submisso Anvisa deva ocorrer ainda em 2026